
ZWS Stock Forecast & Price Target
ZWS Analyst Ratings
Bulls say
Zurn Elkay Water Solns is supported by a durable, specification-driven portfolio tied to defensive nonresidential end markets, with education and healthcare representing 80% of institutional exposure and about 39% of total sales, helping insulate demand through cyclical noise. Its fundamentals are strengthened by best-in-class profitability, with adjusted EBITDA margins around 26% and 3Q26 adjusted EBITDA of $140 million on 150 bps of margin expansion, while free cash flow conversion of 126% underscores unusually strong cash generation. Management’s raised 2026 adjusted EBITDA guidance to $512-$515 million, 0.4x net leverage, and roughly $400 million of served-market expansion in 2026 also signal ample balance-sheet flexibility, margin durability, and growth optionality through M&A, buybacks, and adjacency expansion.
Bears say
Zurn Elkay Water Solns is facing a softer near-term demand backdrop as management cut 4Q26 organic growth guidance from mid-single digits to 3%-5%, signaling caution amid macro uncertainty and deferred institutional budgets in education and healthcare. The bearish case also centers on a premium valuation that leaves little room for disappointment, especially if institutional and commercial construction/remodeling slows, share gains stall, or distributor/specification losses pressure volume and mix. Further downside could come from execution or M&A missteps, commodity volatility in copper, brass, steel, plastics, and electronics, or weaker adoption of higher-margin touchless and IoT products, any of which could compress margins and erode the stock’s premium versus peers.
This aggregate rating is based on analysts' research of Zurn Elkay Water Solutions and is not a guaranteed prediction by Public.com or investment advice.
ZWS Analyst Forecast & Price Prediction
Start investing in ZWS
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Zurn Elkay Water Solutions (ZWS) Forecast
ZWS Analyst Forecast & Price Prediction
Start investing in ZWS
Order type
Buy in
Order amount
Est. shares
0 shares